Sino Biological,Inc.
义翘神州
301047
Shenzhen Stock Exchange
Company Profile
The company's core competitiveness is mainly reflected in the following five aspects: 1. Advantage of independent and autonomous technology platform Various biological research and development units have diversified demands for biological reagents and technical services, and have higher requirements for timeliness. The company has a perfect and comprehensive technology platform for biological reagents and technical services, and does not need to rely on other manufacturers for product development and production, so it can quickly follow up the trends and hotspots of research in the field of life sciences, and timely develop and produce a wide range of reagent products to meet the needs of customers and the market. At the same time, as the company's R&D and production technology platforms are all independently controlled, it can supply various products and services stably over a long period of time, which has stronger anti-risk ability and cost control ability and ensures the company's long-term stable development. 2、Relatively closed-loop R&D system advantages The company has constructed a full set of key technologies and 5 core technology platforms for innovative R&D of biological reagents with protein and antibody as the core, and currently produces and sells more than 77,000 kinds of off-the-shelf products, including more than 9,800 kinds of recombinant proteins, 15,000 kinds of antibodies, more than 50,000 kinds of genes, and series of products of serum-free medium with excellent performance, which are able to cover multiple fields of life science research. The company comprehensive R&D system has helped us establish a complete and large-scale product system to provide customers with “one-stop” procurement experience of research reagents and services,so as to meet their diverse R&D and production needs. on the other hand, some of the key reagents required in the company's R&D and production processes can be independently developed and customized, which can effectively improve the efficiency of R&D and success rate and reduce the cost of R&D and production. 3. Team Strengths The company boasts a large, highly qualified technical, management, and marketing team. It brings together talents from immunology, cell biology, bioengineering, and other fields, achieving multidisciplinary integration. Over 30% of employees hold master's or doctoral degrees. Currently, the company maintains a professional R&D team anchored by high-level overseas returnees and supported by young and middle-aged talents. This team possesses not only solid professional expertise but also extensive industry experience and innovative thinking, providing robust talent assurance for new product development and technical services. 4. Global Market Presence Advantage In recent years, the company has actively expanded its overseas market footprint, establishing international sales and technical support teams in the United States, Germany, Japan, and South Korea, while also acquiring SignalChem Biotech Inc., a Canadian enzyme and protein manufacturer. This global market presence enables the company to swiftly grasp market dynamics and efficiently address customer inquiries and service needs regarding product selection, technical specifications, and experimental procedures. It delivers rapid, timely product supply and high-quality technical support to local clients, effectively enhancing product accessibility and customer experience. Currently, the company's business spans over 90 countries and regions worldwide, serving a cumulative customer base exceeding 11,000 clients with whom stable cooperative relationships have been established. 5. Brand Advantages The company has been deeply cultivating in the field of biological reagents for many years, and has formed a good market reputation by virtue of its rich reagent product libraries, professional service level, stable quality and competitive price, covering Tsinghua University, Peking University, Fudan University, the University of Pennsylvania, Stanford University and other domestic and international well-known scientific research institutes and pharmaceutical R&D enterprises, such as WuXi Kande and Sanofi. The company actively supports domestic and foreign researchers to conduct high-level scientific research in the field of life sciences and pharmaceuticals. According to statistics, the company's products and technical services have supported various scientific research institutions to publish more than 10,000 papers since 2017, of which more than 200 papers were published in the world's top journals in the field of life sciences, such as Science, Nature, and Cell, which reflects the company's products' good This reflects the good quality of the Company's products and their effective support for life science research.
Full description
The Company is a biotechnology company engaged in the research and development, production, sales and provision of technical services of biological reagents, and its main business includes recombinant proteins, antibodies, genes and culture media, as well as recombinant proteins, antibodies development and bioanalytical testing and other services. The company has constructed a full set of key technologies and 5 core technology platforms for innovative research and development of biological reagents with proteins and antibodies as the core, and currently produces and sells more than 77,000 off-the-shelf products, including more than 9,800 types of recombinant proteins, 15,000 types of antibodies, more than 50,000 types of genes, and series of products of serum-free media with excellent performance, which are able to cover many fields of life science research, providing services for covering a wide range of life science research areas, providing a “one-stop” channel for the procurement of biological reagent products and technical services for basic scientific research in molecular biology, cell biology, immunology, developmental biology, stem cell research and innovative drug discovery and development. The company focuses on providing high-quality biological reagents and high-level technical services to drug research and development enterprises and life science research institutes around the world. At present, the company has subsidiaries in Suzhou, Taizhou, the U.S., Europe, Japan and other places, and its products are sold to more than 90 countries and regions around the world, with a cumulative number of customers of more than 11,000, covering all kinds of domestic and international biological research and development units, such as universities, scientific research institutes, pharmaceutical research and development enterprises, and so on.